<DOC>
	<DOCNO>NCT00204542</DOCNO>
	<brief_summary>Topical treatment mild moderate actinic keratosis locate face head Solaraze® know safe efficient treatment option . However , unclear expansion treatment period 6 month increase rate complete response . Therefore investigator evaluate efficacy safety treatment actinic keratosis Solaraze® apply twice daily face head 3 6 month treatment .</brief_summary>
	<brief_title>Comparison Efficacy Tolerability Solaraze 3 Versus 6 Months Patients With Mild Moderate Actinic Keratosis Located Face Head</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Photosensitivity Disorders</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Visible histologically proven actinic keratosis Prepared able give write informed consent ≥ 18 80 year age Prepared comply study requirement , include follow : application gel treatment area twice day , 5 / 7 clinic visit prestudy , treatment , posttreatment , followup period Pre posttreatment biopsy histological confirmation ( clearance ) actinic keratosis diagnosis Data clinically significant , unstable , cardiovascular haematologic , hepatic , neurologic , renal , endocrine , collagenvascular , gastrointestinal abnormality diseases Known allergy excipient study drug Any dermatological disease and/or condition treatment surround area ( 3 cm distance treatment area ) may exacerbate treatment diclofenac cause difficulty examination Active chemical dependency alcoholism , assess investigator Currently participate another clinical study complete another clinical study investigational drug within past 30 day Received topical treatment treatment area imiquimod 5FU within time period 1 month Invasive tumour within treatment area , e.g . merkel cell carcinoma , squamous cell carcinoma , basal cell carcinoma , latter accept completely surgically remove</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>actinic keratosis</keyword>
	<keyword>diclofenac sodium</keyword>
</DOC>